Noninvasive identification of proliferative hepatocellular carcinoma based on CEUS quantitative morphological feature.

Authors

Daohui Yang, Huanzhong Su, Xiaoling Chen, Lewu Lin, Xuejun Chen, Feng Mao, Lingyun Yu, Jingmei Zheng, Minrong Wu, Qing Lu

Published in

European journal of radiology. Volume 203. Pages 113016. Jun 16, 2026. Epub Jun 16, 2026.

Abstract

To investigate the diagnostic performance of the quantitative morphological feature of solidity in preoperative prediction of proliferative hepatocellular carcinoma (HCC), and to compare the diagnostic performance between quantitative morphological features and machine learning (ML) models that incorporate Sonazoid contrast-enhanced ultrasound (CEUS) and clinical features.
This retrospective two-center study included 395 patients with histopathologically confirmed HCC. The morphological feature of solidity, along with clinical and CEUS features, was analyzed to predict the proliferative status of HCC. Eight ML models were trained and validated using area under the curve (AUC), calibration, and decision curve analysis (DCA). SHAP interpretability tools were used to elucidate feature contributions.
Solidity emerged as the strongest independent predictor of proliferative HCC with AUC of 0.836 and 0.768 in the two-center cohorts, respectively. The LightGBM model, which integratedsolidity, AFP ≥ 400 ng/mL, ratio of neutrophils to lymphocytes (N/L), ten-min ratio, and standard deviation (StdDev) of lesion, achieved superior performance, with AUCs of 0.887 (95% CI: 0.803-0.971) and 0.871 (0.791-0.948) in internal and external validation, respectively, significantly surpassingsolidity(P = 0.0026 and 0.0067) and LightGBM-4F (P = 0.0004 and 0.033). Robustness was confirmed via 10-fold cross-validation (mean AUC = 0.897). Calibration curves and DCA confirmed the clinical utility across cohorts. SHAP analysis highlightedsolidity(mean impact = 1.38) as the dominant predictor, followed by AFP (mean = 0.7).
Our interpretable ML model leverages quantitative CEUS features, spearheaded by the morphological biomarker solidity, to preoperatively predict HCC proliferative status. This enables noninvasive risk stratification, facilitating precision treatment planning.

PMID:
42320144
Bibliographic data and abstract were imported from PubMed on 20 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.